Moderna Inc
NASDAQ: MRNA
$33.76
-$2.20 (-6.1%)
Closing Price on March 11, 2025
MRNA Stock Chart and Intraday Price
MRNA Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Address | 200 TECHNOLOGY SQUARE, CAMBRIDGE, MA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 36,319.86M USD |
| Shares Outstanding | 382,073,000 |
MRNA Articles
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the past week.
Published:
Star portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4. As usual, there were many moves into and out of the investment...
Published:
NVIt’s the start of a new trading week, but little has changed since Friday. In premarket trading, the dominant factor weighing on markets is the rise of 10-year Treasury prices which hit a...
Published:
Of the 503 stocks in the S&P 500 (some companies have two classes of stocks that are included) fewer than 30% of them, or 148 stocks, beat the index’s average return of 23.31% in 2024. 24/7...
Published:
The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been incredible. This period of time really reminds me of the post-pandemic rally we...
Published:
Tech stocks look poised to build on recent gains in premarket trading on Monday. Nasdaq Futures are up in the most in Futures trading as of 9:00 a.m. ET: Nasdaq Futures: Up 120.75 (+.55%) S&P 500...
Published:
If you’re invested in companies like Palantir (Nasdaq: PLTR), MicroStrategy (Nasdaq: MSTR), or Axon Enterprises (Nasdaq: AXON), tomorrow is a day that should be circled on your calendar. ...
Published:
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher. Federal Reserve chairman Jay Powell gave his strongest...
Published:
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Published:
Invesco QQQ Trust (NASDAQ: QQQ) is an ETF that tracks the performance of the 100 largest companies listed on the Nasdaq. While this is mainly made up of technology companies, it holds the stocks in...
Published:
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Published:
2018 was one of the last full years we would feel normal as a world for a long time. We had no idea what was hurling around the corner. That year, Drake led the charts with “God’s Plan” and...
Published:
U.S. stocks are adding to Wednesday's comeback with solid gains after about half an hour of trading Thursday morning. Here are winners and losers.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.